Table 1.
Patient baseline characteristics
| Characteristic | All study patients (N = 985) |
|---|---|
| Female sex | 457 (46) |
| Age, y | |
| Median (IQR) | 80 (13) |
| ≥ 85 | 290 (29) |
| 75–84 | 394 (40) |
| 65–74 | 195 (20) |
| < 65 | 106 (11) |
| CHADS2 prior to index event | |
| Mean (SD) | 1.7 (1) |
| 5–6 | 4 (0.4) |
| 3–4 | 113 (11) |
| 1–2 | 697 (71) |
| 0 | 171 (17) |
| Medical history | |
| Prior stroke or TIA | 112 (11) |
| Prior bleeding event | 29 (3) |
| Index event type | |
| Stroke | 497 (50) |
| TIA | 488 (50) |
| Length of stay, d, median (IQR) | 2 (7) |
| Follow-up, d, median (IQR) | 643 (836) |
| Deaths during follow-up | 316 (32) |
| Creatinine clearance, mL/min | |
| ≥ 90 | 78 (8) |
| 50–89 | 578 (59) |
| 30–49 | 264 (27) |
| 15–29 | 26 (3) |
| ≤ 14 | 1 ( < 1) |
| Not documented | 38 (4) |
Values are n (%), unless otherwise indicated.
CHADS2,Congestive Heart Failure, Hypertension, Age ≥ 75, Diabetes, and Prior Stroke/TIA [doubled] score; IQR, interquartile range; SD, standard deviation; TIA, transient ischemic attack.